Seven Joy Kang Shiliuyunyi and Hansoh Pharmaceutical (HK03692) Deepen Strategic Collaboration to Co-Build a New Ecosystem for the Medical and Health Industry

Since the collaboration between Sevenlecare Pomegranate Cloud Hospital and Hansoh Pharma (HK03692) in the field of chronic disease specialty drugs, both parties have achieved remarkable results in the area of chronic disease medical services. Building on the successful operational experience gained over the past year, the two sides have further deepened their cooperation. Through resource integration and innovative synergy, they are jointly promoting the construction of an ecosystem for the pharmaceutical health industry, ushering in a new era of high-quality development.

Hansoh Pharma, as a benchmark for innovative Chinese pharmaceutical listed enterprises with a market value of over 100 billion yuan, has made continuous breakthroughs in multiple major disease areas by virtue of its excellent R&D capabilities and comprehensive production system. Its innovation ability and market influence have been highly regarded. As the largest online chronic disease prescription platform in China, Seven Happiness Group's "Pomegranate Cloud Hospital" Internet hospital builds a full-link service system of "medical + pharmaceutical + patient" relying on digital innovation technology, committed to improving the accessibility of medical services and providing patients with more convenient and efficient healthcare services.

Since the cooperation between the two parties, they have fully utilized their respective differentiated advantages in pharmaceutical R&D, production, and Internet medical services. They have engaged in in-depth cooperation in areas such as pharmaceutical promotion, patient education, and doctor-patient services, jointly creating an efficient platform for the collaboration and interconnection of doctors, patients, medications, and enterprises. This cooperative model has created significant social market value, gained widespread recognition from doctors and patients, set an industry benchmark for the cross-sector integration of "Internet + pharmaceuticals," and laid a solid foundation for further deepening the cooperation between the two parties.

In 2025, the two parties signed a deeper strategic cooperation agreement. Through strategic synergy, technical integration, and model innovation, they will further improve the efficiency and quality of medical services. Driven by the dual engines of industrial digitalization and pharmaceutical innovation, Sevenlecare Pomegranate Cloud Medicine and Hansoh Pharma will continue to lead the transformation of the pharmaceutical and health industry. They will inject new momentum into building a universal, efficient, and intelligent medical and health service system, jointly promoting the high-quality development of the pharmaceutical and health industry.